Investing.com – Illumina (NASDAQ: ) reported third quarter EPS of $1.14, $0.26 better than the analyst estimate of $0.88. Revenue for the quarter came in at $1.08B versus the consensus estimate of $1.08B.
Guidance
Illumina sees Q4 2024 revenue of $1.07B versus the analyst consensus of $950.00M.
Illumina sees FY 2024 EPS of $4.05-$4.15 versus the analyst consensus of $3.91.
Illumina’s stock price closed at $153.49. It is up 21.14% in the last 3 months and up 35.08% in the last 12 months.
Illumina saw 7 positive EPS revisions and 11 negative EPS revisions in the last 90 days. See Illumina’s stock price’s past reactions to earnings here.
According to InvestingPro, Illumina’s Financial Health score is “fair performance“.
Check out Illumina’s , and Illumina’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
